Contents

Current Pharmaceutical Design, Volume 13 - Number 7

Editorial [Hot Topic: Targeting the IGF-I Receptor Signaling Pathway:Implications for Human Cancer Therapy (Executive Editors: A. Ciampolillo and F. Giorgino) ]

, 13(7): 661 - 662

Anna Ciampolillo and Francesco Giorgino


DOI: 10.2174/138161207780249137




The IGF-I Signaling Pathway

, 13(7): 663 - 669

Luigi Laviola, Annalisa Natalicchio and Francesco Giorgino


DOI: 10.2174/138161207780249146




The Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer

, 13(7): 671 - 686

Antonino Belfiore


DOI: 10.2174/138161207780249173




Anti-Apoptotic Actions of Insulin-Like Growth Factors: Lessons from Development and Implications in Neoplastic Cell Transformation

, 13(7): 687 - 703

Isabel Varela-Nieto, Markus Hartl, Itziar Gorospe and Yolanda Leon


DOI: 10.2174/138161207780249164




Crosstalk between IGF Signaling and Steroid Hormone Receptors in Breast Cancer

, 13(7): 705 - 717

Diego Sisci and Eva Surmacz


DOI: 10.2174/138161207780249182




The IGF Axis in Prostate Cancer

, 13(7): 719 - 727

S. Monti, L. Proietti-Pannunzi, A. Sciarra, F. Lolli, P. Falasca, M. Poggi, F. S. Celi and V. Toscano


DOI: 10.2174/138161207780249128




The IGF-I Axis in Thyroid Carcinoma

, 13(7): 729 - 735

A. Ciampolillo, C. De Tullio, E. Perlino and E. Maiorano


DOI: 10.2174/138161207780249209




Anti-Tumor Activity of Non-Nucleosidic Reverse Transcriptase Inhibitors

, 13(7): 737 - 747

Matteo Landriscina, Corrado Spadafora, Mauro Cignarelli and Carlo Barone


DOI: 10.2174/138161207780249191




Pancreatic Islets Under Attack: Cellular and Molecular Effectors

, 13(7): 749 - 760

Michal Pearl-Yafe, Ayelet Kaminitz, Esma S. Yolcu, Isaac Yaniv, Jerry Stein and Nadir Askenasy


DOI: 10.2174/138161207780249155




Drug Carriers in Pharmaceutical Design: Promises and Progress

, 13(7): 761 - 769

Ranjna C. Dutta


DOI: 10.2174/138161207780249119




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science